Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer--The Triumph of Technology Over Bio
Link ID 747
Title Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer--The Triumph of Technology Over Bio
Url http://www.medscape.com/viewarticle/565392?src=rss
Description Should stage I non-small-cell lung cancer patients who are unsuitable for surgery receive hypofractionated stereotactic radiotherapy? How safe is this form of radiation treatment?
Nature Clinical Practice Oncology
Category Articles > Hematology-Oncology
Keywords
Date Nov 14, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. ESAs Should Continue to be Used for Anemia in Cancer Patients, Says FDA Advisory Committee
  Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Biologic Differences in Breast Cancer: An Expert Interview With Dr. Lisa Carey
  In this Expert Interview, Lisa Carey, MD, discusses the biologic differences that underlie differences in breast tumor behavior and outcomes.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. Unique Pattern of Nuclear TdT Immunofluorescence Distinguishes Normal Precursor B Cells (Hematogones
  Normal precursor B cells and lymphoblasts of precursor B-ALL may be hard to distinguish. How is an immunofluorescence test for TdT that can differentiate hematogones from leukemic blasts applied?
American Journal of Clinical Pathology
Category:   Articles > Hematology-Oncology


4. Novel Drug Combinations for Advanced Breast Cancer
  In this Expert Interview from SABCS 2007, Dr. William J. Gradishar details the latest novel drug combinations that may benefit patients with advanced breast cancer.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Alpha1-Antitrypsin Deficiency Significantly Increases Risk for Lung Cancer
  Carriers of the alpha1-antitrypsin deficiency might have a risk of developing lung cancer that is up to 70% higher than that for noncarriers of the genetic defect. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS